New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.
AVNS - Avanos Medical, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$26.00
LOW:
$20.00
MEDIAN:
$23.00
CONSENSUS:
$23.00
DOWNSIDE:
6.54%
Stock News
Deciphering Avanos Medical (AVNS) International Revenue Trends
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Helix Energy Solutions Group, Inc. (NYSE – HLX), TopBuild Corp. (NYSE – BLD), Avanos Medical, Inc. (NYSE – AVNS), Affinity Bancshares (Nasdaq – AFBI)
BALA CYNWYD, Pa. , May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith. com) or Marc Ackerman (mackerman@brodskysmith. com) at 855-576-4847.
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.
Avanos Medical, Inc. Announces First Quarter 2026 Results
Delivered double-digit organic growth led by Specialty Nutrition Systems segment Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per share On April 14, 2026, announced the execution of a definitive agreement to be acquired by certain affiliates of American Industrial Partners ("AIP") in an all-cash offer at an enterprise value of $1.272 billion ALPHARETTA, Ga., May 5, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2026 financial results.
Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, April 23, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial.
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that le.
Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium
AVNS stock jumps after agreeing to a $1.27B all-cash buyout by AIP at a 72% premium, offering shareholders immediate value and setting up a private-market shift.
Avanos Medical Inc (AVNS) Stock Up 69.5% but GF Value Says Overvalued -- GF Score: 73/100
On April 14, 2026, Avanos Medical Inc (AVNS) shares rose significantly by 69.5%, bringing the current price to $24.63. The stock has shown impressive performanc
This Healthcare Stock Is Rising 69%. It's Getting Bought Out for a Big Premium.
Avanos Medical agrees to be acquired by the private-equity firm American Industrial Partners in an all-cash deal worth $1.27 billion.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avanos Medical, Inc. (NYSE: AVNS)
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Avanos Medical, Inc. (NYSE: AVNS ) related to its sale to affiliates of American Industrial Partners.
Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, April 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Avanos (NYSE: AVNS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with American Industrial. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.
AVNS Stock Alert: Halper Sadeh LLC is Investigating Whether Avanos Medical, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners for $25.00 per share in cash.Halper Sadeh encourages Avanos shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected] investigation concerns whether Avanos and its board of.
AIP to take Avanos Medical private in a deal valued at about $1.27 billion
Avanos Medical said on Tuesday it has agreed to be bought by affiliates of American Industrial Partners (AIP) in an all-cash deal worth about $1.27 billion.
Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
Avanos Stockholders To Receive $25.00 Per Share in Cash ALPHARETTA, Ga. and NEW YORK, April 14, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners ("AIP"), an operationally-oriented industrials investor, in an all-cash transaction that values Avanos at an enterprise value of approximately $1.272 billion.
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Avanos Medical, Inc. (NYSE: AVNS)
NEW YORK, March 17, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Avanos Medical, Inc. (NYSE: AVNS) on behalf of the company's shareholders. The investigation seeks to determine whether Avanos Medical's directors breached their fiduciary duties in connection with recent corporate actions.
Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript
Avanos Medical, Inc. (AVNS) Presents at The Citizens Life Sciences Conference 2026 Transcript
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer, will participate in a fireside chat at the 2026 Citizens Life Sciences Conference on Wed.
Price Targets
Avanos Medical (AVNS) PT Lowered to $20 at Stifel
$20.00
(was $18.58)
Rick Wise
·
Stifel Nicolaus
Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $26
$26.00
(was $26.99)
Morgan Stanley
Stifel Maintains Hold on Avanos Medical, Lowers Price Target to $28
$28.00
(was $26.89)
Stifel Nicolaus
Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $28
$28.00
(was $27.19)
Morgan Stanley
Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $33
$33.00
(was $29.29)
Morgan Stanley